The report provides a detailed analysis essential for establishing a Betahistine Hydrochloride production plant. It encompasses all critical aspects necessary for Betahistine Hydrochloride production, including the cost of Betahistine Hydrochloride production, Betahistine Hydrochloride plant cost, Betahistine Hydrochloride production costs, and the overall Betahistine Hydrochloride production plant cost.
Additionally, the study covers specific expenditures associated with setting up and operating a Betahistine Hydrochloride production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Betahistine Hydrochloride is an agent that is useful for the management of Meniere’s disease, an inner ear disorder that can lead to episodes of vertigo, deafness, ringing in the ear and fullness in the affected ear. It binds up with body’s histamine receptors and is therefore instrumental in the control of blood flow and pressure in the vestibular system or the inner ear. It is also effective for decreasing the intensity and the frequency of the vertigo connected with Meniere’s disease through regulating these receptors.
The procurement of Betahistine Hydrochloride is influenced by its application in the pharmaceutical and medical industries as a histamine analog used to treat Meniere’s disease and related disorders.
The widespread occurrence of Meniere’s disease is significantly increasing the demand for Betahistine Hydrochloride. The therapeutic benefits of Betahistine Hydrochloride in the treatment of vertiginous symptoms have been validated by recent meta-analyses. These benefits are especially evident in the cases of cupulo-canalolithiasis and vertigo resulting from vertebrobasilar arterial insufficiency. Its usage as a successful treatment option is supported by this research, which is generating demand among healthcare practitioners.
The maximum efficacy of Betahistine Hydrochloride is achieved with longer treatment durations and optimal dosing, which encourages consistent use among patients, contributing to rising market demand. It is widely available and can be prescribed for various vertiginous conditions, making it a readily accessible treatment option for patients, which enhances its market presence. It has a favorable safety profile, and most of the side effects are rare with its administration.
This optimal safety profile reassures healthcare practitioners to add Betahistine Hydrochloride into the pharmaceutical regimen for patients, contributing to its demand. Overall, industrial Betahistine Hydrochloride procurement is influenced by its application in the pharmaceutical and medical industries, rising cases of Meniere’s disease and related disorders, greater efficacy, fewer side effects, better tolerability, long-term usage, and regulatory approvals.
Raw Material for Betahistine Hydrochloride Production
According to the Betahistine Hydrochloride production plant project report, the key raw materials used in the production of Betahistine Hydrochloride include paraformaldehyde-2-methylpyridine.
Production Process of Betahistine Hydrochloride
The extensive Betahistine Hydrochloride production cost report consists of the following major industrial production process:
- Production from paraformaldehyde and 2-methylpyridine: The production process of Betahistine Hydrochloride starts with the condensation of paraformaldehyde and 2-methylpyridine to form 2-(2-pyridyl)ethanol. This compound is dehydrated with acetic anhydride under reflux to give 2-vinylpyridine. The compound is reacted with methylamine to form Betahistine. Betahistine is reacted with gaseous hydrochloride in the presence of absolute ethanol to produce Betahistine Hydrochloride.
Betahistine Hydrochloride, commercially known as Serc, Betaserc, Veserc, Hiserk, and Vergo, is a hydrochloride salt of Betahistine. It is a pale-yellow powder having the molecular formula C8H13ClN2 and a molecular weight of 172.65 g/mol. It has an estimated water solubility of 49.3 mg/mL. It has a log P value of 0.59. The value of its dissociation constant, pKa, is 9.77. It is a histamine analog used to treat Meniere’s disease and related disorders.